Research and experimental development on natural sciences and engineering
EUROFINS BIOPHARMA PRODUCT TESTING NORWAY AS
Revenue 2024
NOK 1.2m
Operating profit
NOK 452,000
Equity
NOK 696,000
Incorporated
2023
Share capital
NOK 30,000
Roles
Daglig lederJan Rando
Revisor
Styrets lederSvend Aage Linde
StyremedlemJon Ragnar Røed
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| EUROFINS BIOPHARMA PRODUCT TESTING | 100.0% | 30000.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.